Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer.
Robertson JM, Margolis J, Jury RP, Balaraman S, Cotant MB, Ballouz S, Boxwala IG, Jaiyesimi IA, Nadeau L, Hardy-Carlson M, Marvin KS, Wallace M, Ye H.
Robertson JM, et al. Among authors: cotant mb.
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e187-92. doi: 10.1016/j.ijrobp.2010.08.050. Epub 2011 May 5.
Int J Radiat Oncol Biol Phys. 2012.
PMID: 21549514
Clinical Trial.